IMMUNITYBIO, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-242.2M | $181.1M |
| FY2022 | — | $-447.3M | $104.6M |
| FY2023 | — | $-587.0M | $265.5M |
| FY2024 | — | $-489.1M | $143.4M |
| FY2025 | — | $-500.5M | $88.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-242.2M | $181.1M |
| FY2022 | — | $-447.3M | $104.6M |
| FY2023 | — | $-587.0M | $265.5M |
| FY2024 | — | $-489.1M | $143.4M |
| FY2025 | — | $-500.5M | $88.3M |